Tag - pharmaceuticals

 
Menu
Search
 
May 17, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

PHARMACEUTICALS

Japan Times
WORLD / Science & Health
May 14, 2020
France says ‘unacceptable’ for U.S. to get Sanofi vaccine first
Giving the U.S. priority access to a Sanofi vaccine against the new coronavirus would be "unacceptable,” a French government minister said.
Japan Times
BUSINESS
May 14, 2020
Takeda says trial based on blood of recovered virus patients could start in July
Fighting disease with blood from survivors is an ancient strategy that has not been well tested for the novel coronavirus.
Japan Times
JAPAN / Science & Health
May 13, 2020
Japan's health insurance to cover ¥167 million gene therapy drug
Considered the world's most expensive medicine, relatively few cases are expected to require the one-time dosage of drug to treat spinal muscular atrophy.
Japan Times
ASIA PACIFIC / Science & Health
May 13, 2020
A tale of two Japanese drugs in tests to fight COVID-19
Avigan and camostat are undergoing trials as they may be effective in treating illnesses brought on by coronavirus.
Japan Times
JAPAN / FOCUS
May 12, 2020
Abe follows Trump's example, approving drugs quickly after criticism
Japanese regulators are usually known for taking a year to approve new drugs, but authorized remdesivir just three days after receiving the application.
Japan Times
BUSINESS
May 8, 2020
Drugmaker Shionogi rushing to launch coronavirus vaccine in 2021
It is rare to study production before getting the results of clinical trials, but the Japanese drugmaker wants a vaccine on the market as fast as possible.
Japan Times
WORLD / Science & Health
May 2, 2020
U.S. emergency approval broadens use of Gilead's COVID-19 drug remdesivir
Gilead Science Inc.'s antiviral drug remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration for COVID-19 on Friday, clearing the way for broader use of the drug in more hospitals around the United States.
Japan Times
WORLD / Science & Health
May 1, 2020
Virus drugmaker caught between making a profit and treating the world
Gilead Sciences Inc. may spend $1 billion on its breakthrough new treatment for COVID-19 this year alone, Chief Executive Officer Daniel O’Day said. How much revenue — if any — the company expects to generate is another matter.
Japan Times
JAPAN / Science & Health
Apr 28, 2020
Remdesivir drug to be approved for coronavirus patients in May
This is the first time the government has used the streamlined process since the pandemic started.
Japan Times
BUSINESS
Apr 27, 2020
Shionogi to develop coronavirus vaccine, with trials eyed for this year
Shionogi & Co. said Monday it will develop a vaccine for the novel coronavirus with the aim of starting clinical trials this year.
Japan Times
WORLD / Science & Health
Apr 26, 2020
Countries and companies risk billions in race for coronavirus vaccine
Governments, charities and Big Pharma firms are making huge bets with extraordinarily low odds of success.
Japan Times
WORLD
Apr 23, 2020
Official says he was ousted for urging caution on Trump-touted virus drug
The ousted director of a key U.S. agency charged with developing drugs to fight the COVID-19 pandemic said Wednesday he was dismissed because he called for careful vetting of a treatment frequently touted by President Donald Trump.
Japan Times
JAPAN / FOCUS
Apr 23, 2020
Abe touts Avigan as COVID-19 treatment despite experts urging caution
Medical experts warn the drug, also known as favipiravir, may cause birth defects and it cannot be administered to expecting mothers or those who may become pregnant.
Japan Times
WORLD / Science & Health
Apr 22, 2020
Hydroxychloroquine, championed by Trump for virus, may raise death risk
An old malaria drug touted by U.S. President Donald Trump as a "game changer" in the fight against the coronavirus provided no benefit and potentially higher risk of death for patients at U.S. veterans hospitals, according to an analysis that has been submitted for expert review.
Japan Times
BUSINESS / Companies
Apr 15, 2020
Fujifilm to boost capacity to make COVID-19 treatment Avigan
Fujifilm Holdings Corp. said Wednesday it has expanded manufacturing capacity to "significantly increase" production of its anti-flu drug Avigan that is being tested as a treatment for COVID-19.
Japan Times
WORLD / Science & Health
Apr 14, 2020
Coronavirus drug hopefuls are cheap to make but may quickly be in short supply
Drugs being repurposed in hopes they will help against COVID-19 cost relatively little to make but may prove challenging to produce in quantities needed for a pandemic, a drug pricing expert has said.
Japan Times
ASIA PACIFIC / Science & Health
Apr 7, 2020
After Trump threat, India lifts export ban on COVID-19 treatment drug
India has partially lifted a ban on the exports of a malaria drug after U.S. President Donald Trump sought supplies for the United States, according to government officials with knowledge of the matter.
Japan Times
JAPAN / Science & Health
Apr 7, 2020
Japan to offer anti-flu Avigan drug to 20 virus-hit nations for free
Japan plans to provide the anti-flu drug Avigan for free to 20 countries hoping to use it to treat coronavirus patients, Foreign Minister Toshimitsu Motegi said Tuesday.
Japan Times
WORLD / Science & Health / FOCUS
Apr 6, 2020
Fast-moving virus pits treating patients against finding a cure
Pharmaceutical research experts are raising concerns that attempts to offer desperate coronavirus patients some form of treatment may hobble crucial studies of which drugs actually work and which ones don't.
Japan Times
JAPAN / Science & Health
Apr 5, 2020
Japan to boost Avigan drug stockpile as part of coronavirus stimulus
Japan is considering increasing the stockpile of Fujifilm Holding Corp.'s Avigan anti-flu drug during this fiscal year so it can be used to treat 2 million people.
Japanese stripper bids to have her porn movies taken off internet
Plaintiff Miyuki Ariga (left) speaks at a news conference along with her lawyer, Yoshitomo Morohashi, after filing a lawsuit at the Tokyo District Court on Monday.
Kishida defends planned rule to revoke foreigners' residency
Prime Minister Fumio Kishida speaks during a meeting of the Lower House Judicial Affairs Committee on Wednesday.
Human bone-like objects found at Nippon Steel plant’s molten iron pot, with one worker missing
Police believe it’s highly possible that human bones found in a molten iron pot at Nippon Steel's Oita factory belong to a missing male employee.
Was Onosato's defeat of Terunofuji an era-defining bout?
Onosato (right) defeats Terunofuji at the Ryogoku Kokugikan in Tokyo on May 12. While nothing in sumo is guaranteed, it seems almost inevitable that Onosato is destined for the top of the sport's pyramid.
Japanese billionaire sues Meta over investment scams using his image
Entrepreneurs Yusaku Maezawa (second from right) and Takafumi Horie (third from right) attend a study session on fake social media ads and investment scams at the Liberal Democratic Party headquarters in Tokyo on April 10.
Japanese rap creates its mecca in Pop Yours
Tokyo-based artist Jumadiba says he forgoes the label of simply “rap” for his music because the Japanese rap scene isn’t confined to a particular sound.
Who’s toughest on China? Biden’s tariff tactic ups ante as election looms.
U.S. President Joe Biden speaks about new actions to protect American workers and businesses from China's "unfair" trade practices, in the Rose Garden of the White House in Washington on Tuesday.
Was Onosato's defeat of Terunofuji an era-defining bout?
Onosato (right) defeats Terunofuji at the Ryogoku Kokugikan in Tokyo on May 12. While nothing in sumo is guaranteed, it seems almost inevitable that Onosato is destined for the top of the sport's pyramid.
Ishin struggles to set itself apart from other parties
Nippon Ishin no Kai Secretary-General Fumitake Fujita (right) speaks beside Yui Kanazawa, the party's candidate in the Tokyo 15th district by-election on April 28. Nippon Ishin lost in this by-election as well as another in Nagasaki held on the same day.

Podcast

From easily navigable train stations to the helpfulness of its municipal staff, Tokyo has earned high praise for its commitment to accessibility for disabled travelers.
[Rebroadcast] Japan is doing better on accessibility than you may think

Longform

Things may look perfect to the outside world, but today's mom is fine with some imperfection at home.
How 'Reiwa moms' are reshaping motherhood in Japan
By Mai Yoshikawa

SUSTAINABLE JAPAN

Vol. 35: Travel in time — and stay there
Vol. 35: Travel in time — and stay there

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER